Lipitor

  • by July 11, 2005
Lipitor, a cholesterol-reducing drug manufactured by Pfizer, has placed its advertising account in review. Valued between $60 and $80 million, Kaplan Thaler, BBDO Worldwide, J. Walter Thompson, and Merkley + Partners, the incumbent, will compete for the work.
Next story loading loading..